Cargando…

Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism

Proton pump inhibitors are the one of the most widely used drugs in the world. Hypomagnesemic hypoparathyroidism has been reported with different proton pump inhibitors with prolonged oral use. We report the first reported case of possible such effect with intravenous preparation of proton pump inhi...

Descripción completa

Detalles Bibliográficos
Autor principal: Swaminathan, Krishnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450563/
https://www.ncbi.nlm.nih.gov/pubmed/26069375
http://dx.doi.org/10.4103/0253-7613.157135
_version_ 1782374024945336320
author Swaminathan, Krishnan
author_facet Swaminathan, Krishnan
author_sort Swaminathan, Krishnan
collection PubMed
description Proton pump inhibitors are the one of the most widely used drugs in the world. Hypomagnesemic hypoparathyroidism has been reported with different proton pump inhibitors with prolonged oral use. We report the first reported case of possible such effect with intravenous preparation of proton pump inhibitor. This case report raises awareness among physicians worldwide of this often unknown association, as life-threatening cardiac and neuromuscular complications can arise with unrecognized hypocalcemia and hypomagnesemia with proton pump inhibitors.
format Online
Article
Text
id pubmed-4450563
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-44505632015-06-11 Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism Swaminathan, Krishnan Indian J Pharmacol Drug Watch Proton pump inhibitors are the one of the most widely used drugs in the world. Hypomagnesemic hypoparathyroidism has been reported with different proton pump inhibitors with prolonged oral use. We report the first reported case of possible such effect with intravenous preparation of proton pump inhibitor. This case report raises awareness among physicians worldwide of this often unknown association, as life-threatening cardiac and neuromuscular complications can arise with unrecognized hypocalcemia and hypomagnesemia with proton pump inhibitors. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4450563/ /pubmed/26069375 http://dx.doi.org/10.4103/0253-7613.157135 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Drug Watch
Swaminathan, Krishnan
Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism
title Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism
title_full Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism
title_fullStr Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism
title_full_unstemmed Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism
title_short Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism
title_sort proton pump inhibitor-induced hypomagnesemic hypoparathyroidism
topic Drug Watch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450563/
https://www.ncbi.nlm.nih.gov/pubmed/26069375
http://dx.doi.org/10.4103/0253-7613.157135
work_keys_str_mv AT swaminathankrishnan protonpumpinhibitorinducedhypomagnesemichypoparathyroidism